Skye Bioscience (SKYE) Return on Assets (2013 - 2026)
Skye Bioscience (SKYE) posted quarterly Return on Assets of 0.02% for Q1 2026, down 2.0% year-over-year from 0.02% in Q1 2025, and down 49.57% quarter-over-quarter from 0.02% in Q4 2025.
Skye Bioscience (SKYE) Return on Assets (2013 - 2026) Analysis & Trends
Skye Bioscience (SKYE) has reported Return on Assets for 14 consecutive years, with 0.02% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Assets fell 2.0% year-over-year to 0.02%; the TTM figure through Mar 2026 stood at 0.02% (down 2.0% YoY), while the FY2025 annual figure was 0.01%, changed 0.0% from the prior year.
- Return on Assets retreated to 0.02% in Q1 2026 per SKYE's latest filing, from 0.02% in the prior quarter.
- Across five years, Return on Assets topped out at 0.0% in Q3 2024 and bottomed at 0.06% in Q2 2023.
- Historically, Return on Assets has averaged 0.02% across 5 years, with a median of 0.02% in 2025.
- Annual changes were most pronounced in 2023 — Return on Assets decreased 4 bps — and 2024, when it increased 6 bps.
- Skye Bioscience's Return on Assets stood at 0.03% in 2022, then grew by 16 bps to 0.03% in 2023, then jumped by 87 bps to 0.0% in 2024, then slumped by 366 bps to 0.02% in 2025, then tumbled by 50 bps to 0.02% in 2026.
- Business Quant data shows SKYE's Return on Assets at 0.02% in Q1 2026, 0.02% in Q4 2025, and 0.01% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.76 Bn | 130.91 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.15 Bn | 78.15 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.45 Bn | 59.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.08 Bn | 51.94 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 42.08 Bn | 36.99 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 30.90 Bn | 27.59 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 27.76 Bn | 9.37 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.00 Bn | 26.17 Bn | - | 0.00% |
| 10 | Skye Bioscience | 10.36 Mn | 10.36 Mn | - | -0.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.02% |
| Dec 31, 2025 | -0.02% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.03% |
| Sep 30, 2023 | -0.05% |
| Jun 30, 2023 | -0.06% |
| Mar 31, 2023 | -0.03% |
| Dec 31, 2022 | -0.03% |
| Sep 30, 2022 | -0.03% |
| Jun 30, 2022 | -0.02% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | -0.01% |
| Jun 30, 2021 | -0.01% |